X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ABBOTT INDIA SUVEN LIFE/
ABBOTT INDIA
 
P/E (TTM) x 17.0 36.7 46.4% View Chart
P/BV x 3.4 9.5 36.2% View Chart
Dividend Yield % 0.7 0.7 91.4%  

Financials

 SUVEN LIFE   ABBOTT INDIA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
ABBOTT INDIA
Mar-18
SUVEN LIFE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2516,110 4.1%   
Low Rs1553,996 3.9%   
Sales per share (Unadj.) Rs49.11,552.2 3.2%  
Earnings per share (Unadj.) Rs9.7188.8 5.1%  
Cash flow per share (Unadj.) Rs11.4196.4 5.8%  
Dividends per share (Unadj.) Rs1.5055.00 2.7%  
Dividend yield (eoy) %0.71.1 67.9%  
Book value per share (Unadj.) Rs60.3796.6 7.6%  
Shares outstanding (eoy) m127.2821.25 599.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.3 126.9%   
Avg P/E ratio x20.926.8 78.0%  
P/CF ratio (eoy) x17.825.7 69.2%  
Price / Book Value ratio x3.46.3 53.1%  
Dividend payout %15.429.1 53.0%   
Avg Mkt Cap Rs m25,825107,376 24.1%   
No. of employees `0001.13.3 32.3%   
Total wages/salary Rs m6133,937 15.6%   
Avg. sales/employee Rs Th5,832.69,929.3 58.7%   
Avg. wages/employee Rs Th571.51,185.1 48.2%   
Avg. net profit/employee Rs Th1,153.81,207.7 95.5%   
INCOME DATA
Net Sales Rs m6,25332,985 19.0%  
Other income Rs m2331,170 19.9%   
Total revenues Rs m6,48534,155 19.0%   
Gross profit Rs m1,9825,245 37.8%  
Depreciation Rs m213162 131.6%   
Interest Rs m4638 121.2%   
Profit before tax Rs m1,9556,215 31.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,203 32.6%   
Profit after tax Rs m1,2374,012 30.8%  
Gross profit margin %31.715.9 199.3%  
Effective tax rate %36.735.4 103.7%   
Net profit margin %19.812.2 162.6%  
BALANCE SHEET DATA
Current assets Rs m5,62222,655 24.8%   
Current liabilities Rs m1,1686,681 17.5%   
Net working cap to sales %71.248.4 147.1%  
Current ratio x4.83.4 142.0%  
Inventory Days Days8165 125.7%  
Debtors Days Days3629 123.2%  
Net fixed assets Rs m3,325835 397.9%   
Share capital Rs m127213 59.9%   
"Free" reserves Rs m7,54716,715 45.1%   
Net worth Rs m7,67416,928 45.3%   
Long term debt Rs m140-   
Total assets Rs m9,13524,162 37.8%  
Interest coverage x43.2163.7 26.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.4 50.1%   
Return on assets %14.016.8 83.8%  
Return on equity %16.123.7 68.0%  
Return on capital %26.036.9 70.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,066369 1,374.6%   
Fx outflow Rs m2,0013,807 52.6%   
Net fx Rs m3,065-3,438 -89.1%   
CASH FLOW
From Operations Rs m6991,527 45.8%  
From Investments Rs m-6-2,148 0.3%  
From Financial Activity Rs m-577-1,024 56.3%  
Net Cashflow Rs m116-1,646 -7.1%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.1 213.5%  
Shareholders   37,287 18,270 204.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 450 Points Down; All Eyes on State Election Results & Urjit Patel's Resignation(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.1% while the Hang Seng is also up 0.1%.

Related Views on News

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Dec 11, 2018 12:19 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS